Compare Immunovant Inc. Common Stock (IMVT) vs Valley National Bancorp Common Stock (VLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Valley National Bancorp Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Valley National Bancorp Common Stock trades at $12.64 (market cap $6.90B). The key difference: Immunovant Inc. Common Stock and Valley National Bancorp Common Stock are close in size by market cap, and Valley National Bancorp Common Stock pays a 3.53% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Valley National Bancorp Common Stock for 0 Days on average.
| IMVT | VLY | |
|---|---|---|
Market Cap | $6.62B | $6.90B |
Volume | 1,131,364 | 8,032,586 |
Sector | Health | Financials |
52-Week High | $44.96 | $15.19 |
52-Week Low | $17.03 | $9.72 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $9.40B |
Dividend Yield | — | 3.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Valley National Bancorp Common Stock
Valley National Bancorp is a financial holding company whose main subsidiary is Valley National Bank. It provides commercial, retail, trust, and investment services across several U.S. states.
Read more on VLY →
